Results 291 to 300 of about 362,523 (334)

LEAP-006: limits and potential of integrating anti-angiogenic agents into first-line multimodal therapy for non-squamous non-small cell lung cancer. [PDF]

J Thorac Dis
Santo V, Garbo E, Pecci F, Aldea M, Ricciuti B, Gariazzo E.   +5 more
europepmc   +1 more source

Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study [PDF]

, 2018
et al,, Gambacorti-Passerini, Carlo, Van Tine, Brian A   +2 more
core   +1 more source

KAT2A Deficiency Suppresses Lung Cancer Progression by Downregulating MYC Through Decreasing MYC Succinylation

Cancer Science, EarlyView.
ABSTRACT Succinylation has been shown to promote lung cancer development, but its mechanism remains incompletely understood. KAT2A, a succinyltransferase, acts as an oncogene in multiple cancers, but its role in mediating lung cancer progression is unclear.
Junping Li, Feng Zhao, Zhongchao Wang, Shaojun Yang, Zhichao Lu, Xiaoyan Li, Jincheng Song, Zhaoxia Dai   +7 more
wiley   +1 more source

Association between diffusion tensor imaging analysis along the perivascular space (DTI-ALPS)-based glial-lymphatic dysfunction and cognitive impairment in non-small cell lung cancer. [PDF]

Am J Transl Res
Shao W, Li Z, Ge Y, Hu S, Lu H.
europepmc   +1 more source

The Diagnosis and Treatment of Lung Cancer: Methods, evidence and guidance [PDF]

, 2005
Belchamber, C.A., National Collaborating Centre for Acute Care,   +1 more
core  

A11 Peptide Enhances Radiosensitivity by Degrading EphA2 in Nasopharyngeal Carcinoma

Cancer Science, EarlyView.
In EphA2‐high‐expressing nasopharyngeal carcinoma cells, radiation triggers RSK‐dependent phosphorylation of EphA2 at Ser897, which in turn activates AKT and promote radioresistance. The A11 peptide breaks this signaling cascade by degrading EphA2 and blocking its S897 phosphorylation, thereby markedly enhancing radiosensitivity.
Ming Zhang, Zhi‐Qiang Xiao, Wei Huang, Shan‐Shan Lu, Hong Yi, Juan Feng   +5 more
wiley   +1 more source

Safety and efficacy of neoadjuvant immunochemotherapy in non-small-cell lung cancer: a comparative study of patients above and below 70 years. [PDF]

Ther Adv Med Oncol
Zheng Y, Huang M, Luo Q, He Y, Li H, Han X, Zhang L, Shi H.   +7 more
europepmc   +1 more source

Lung Cancer Cells Secrete Glutamine to Accumulate Tumor-Associated Macrophages. [PDF]

Mol Carcinog
Reddy JP, Clague RA, Peixoto BP, Bernstein S, Lauth EE, Takanohashi CY, Kim SC, Wettersten HI.   +7 more
europepmc   +1 more source

PRMT3 Drives IDO1-Dependent Radioresistance and Immunosuppression by Promoting Kynurenine Metabolism in Non-Small Cell Lung Cancer. [PDF]

Cancer Res
Zhang S, Wang S, Wang Y, Zhou T, Yang J, Xu J, Li G, Zhang Y, Wang X, Yin H.   +9 more
europepmc   +1 more source

Patient-derived organoids in non-small cell lung cancer: advances in drug sensitivity testing. [PDF]

Front Pharmacol
Tang W, Tian X.
europepmc   +1 more source